The major histocompatibility complex: a model for understanding graft-versus-host disease.

Abstract excerpt

Acute graft-versus-host disease (GVHD) afflicts as much as 80% of all patients who receive an unrelated donor hematopoietic cell transplant (HCT) for the treatment of blood disorders, even with optimal donor HLA matching and use of prophylactic immunosuppressive agents. Of patients who develop acute GVHD, many are at risk for chronic GVHD and bear the burden of considerable morbidity and lowered quality of life...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Graft vs Host Disease
• Share to Hematologic Neoplasms
• Share to Hematopoietic Stem Cell Transplantation